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Summary The ability to detect photosensitisers in tissue at a microscopical level is important when studying
photodynamic therapy (PDT) in both normal and malignant tissue. We have studied the fluorescence
distribution of aluminium sulphonated phthalocyanine (AlSPc) in the normal rat bladder using a cooled CCD
(charge coupled device) imaging system with computerised image processing. This system makes it possible to
carry out a quantitative assessment of photosensitiser fluorescence in the various layers of the bladder wall.
The highest fluorescence intensities were obtained within I h of intravenous administration but there was little
selectivity of uptake between layers. AlSPc was eliminated from the deeper muscle layers more quickly than
from the superficial layers of the bladder wall so that by 24 h a 4:1 ratio offluorescence intensity was apparent
which persisted at least until 72 h, although the absolute amount of photosensitiser declined. Following
irradiation by red light (675 nm), photobleaching of the sensitiser in the deeper layers further increased this
ratio. Direct absorption of AlSPc by the bladder wall following intravesical administration proved unreliable.
The use of phthalocyanines, and in particular the aluminium
sulphonated derivatives, as experimental photosensitisers for
photodynamic therapy (PDT) is developing rapidly. These
substances have several advantages over haematoporphyrin
derivative (HpD) in terms of chemical purity and stability,
and a major absorption peak in the red part of the spectrum
(675 nm) where there is better tissue penetration. AlSPc has
been shown to be an effective photosensitiser in animal
tumour models for which there appears to be a similar degree
of tumour retention as is found for HpD (Tralau et al.,
1987).
Clinical series of bladder PDT using HpD have shown
some significant complications including bladder irritability
and a greatly reduced bladder capacity, which are probably
the result of unwanted photosensitiser activation and subse-
quent fibrosis in the deep muscle layers of the bladder wall
(Nseyo et al., 1987; Harty et al., 1989). Many photosensitis-
ing agents are relatively poor localisers, achieving only a 2 or
3:1 ratio in tumour vs normal tissue. It is therefore important
to measure the photosensitiser distribution in normal tissue
to minimise adverse effects. In particular it is desirable to
limit the effects to the urothelial and submucosal layers as
the most suitable clinical indication for PDT in urology
appears to be superficial bladder cancer, especially resistant
carcinoma in situ. Gross tissue extraction measurements can-
not give this information whilst standard fluorescent micro-
scopy does not have the required sensitivity to record low
level images free from distortion due to natural background
tissue auto-fluorescence and sensitiser photodegradation.
Initial experiences with a CCD imaging system have been
reported by us previously (Barr et al., 1988), but the system
is now greatly enhanced producing high quality colour
images which can be digitally analysed to determine relative
photosensitiser fluorescence intensities in various parts of the
tissue section (Figure 1). This apparatus could also be used
to study the distribution of porphyrins with suitable adjust-
ments to the excitation and detection wavelengths. In this
paper we report studies of AISPc distribution in normal rat
bladder and how this is influenced by photodegradation. This
information is required to optimise the treatment parameters
for clinical PDT in the bladder.
Materials and methods
Photosensitiser
Aluminium sulphonated phthalocyanine (AISPc) was obtained
from Ciba-Geigy and used after dissolving in 0.9% saline.
This preparation is a mixture of molecules containing on
average three sulphonate groups. A preparation of the
purified disulphonated fraction (S2 - Porphyrin Products
Inc., Logan, Utah) was used for some of the experiments of
intravesical uptake of the photosensitiser.
Preparation ofspecimensforfluorescence scanning
Normal bladder tissue was obtained from female Wistar rats
(approximately 200 g) which received varying concentrations
(0.5-5 mg kg-') of AlSPc (mixture) by tail vein injection. At
intervals after injection the animals were sacrificed and the
bladder catheterised with a fine cannula so that any urine
which might contain photosensitiser could be gently washed
out. Their bladders were then distended to 0.3 ml with OCT
Figure I Fluorescence imaging system.
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medium (Tissue-Tek, Miles Laboratories Inc.) prior to
removal and placing in isopentane (2-methyl butane) which
had been cooled in liquid nitrogen for a few minutes. Speci-
mens froze immediately in this solution and were then stored
in liquid nitrogen. Paired 10 jm transverse sections of intact
bladder were cut using a Cryocat E microtome (Reichert
Ltd), several from each block. Half were used for the
fluorescence studies and the others stained with haematoxylin
and eosin (H&E) to enable orientation of the image.
The direct absorption of intravesically administered photo-
sensitiser was studied after first catheterising and emptying
the bladder in anaesthetised rats. 0.3 ml of AlSPc solution
was instilled for either 30 min or 1 h after which the bladder
was gently washed out several times with saline to remove
any surface dye, before processing as described above. Both
AlSPc mixture and the more lipid soluble S2 fraction were
used at coticentrations ranging from 0.02-0.4 mg ml-.
Fluorescence detection
An inverted microscope (Olympus IMT-2) with epifluorescence
and phase contrast attachments was used, and excitation
light was provided by an 8 mW helium-neon laser emitting at
632.8 nm (Figure 1). A liquid guide was used to direct the
laser output via a 10 nm band pass filter (Omega Optical
Inc., Vermont, USA), centred at 633 nm to remove ex-
traneous light, into the dichroic mirror housing for standard
epifluorescence excitation. The phthalocyanine fluorescence
was detected using a long pass filter (Schott RG665) and a
band pass filter (Omega Optical, Inc.) which transmitted in
the range 665-700 nm and covers the main fluorescence
band of this sensitiser. The principal advantage of using the
helium-neon laser, apart from its spectral purity, is that tissue
auto-fluorescence is significantly reduced for this relatively
long excitation wavelength compared to that seen with con-
ventional UV lamp illumination.
Fluorescence was imaged using a cooled charge-coupled
device (CCD) camera (Wright Instruments, model 1, resolu-
tion 600 x 400 pixels). An IBM PC with a high resolution
colour monitor controlled the camera operation and was
used for digital image processing, display and storage. The
advantages of using a cooled slow-scan CCD camera over
video imaging systems have been discussed previously (Barr
et al., 1988) but briefly they include much higher sensitivity,
direct digital image integration and a linear response over a
signal range of 104 in magnitude. The high sensitivity allows
low power excitation and short integration times which
prevents the occurrence of sensitiser bleaching that may dis-
tort the fluorescence image. Tissue auto-fluorescence from
control 10 jim frozen section amounts to only 1-2 counts on
an image scale of 103 employed in this work. Fluorescence
was digitally quantified by box superimposition over several
representative areas of the tissue section covering the full
thickness of the appropriate tissue layer.
Light exposurefor photobleaching studies
The rat bladder was catheterised with an 18 gauge Teflon
cannula under general anaesthesia. This evenly diffused the
light from the 200 jim laser fibre which was positioned inside
the cannula just short of its tip and centrally within the
bladder. A copper vapour laser (Oxford Lasers) was used,
pumping a dye laser to emit red light at 675 nm. This laser
produces very short (40 ns) pulses of light at 12 kHz and was
set to an average power output of 100 mW. This is well
below the power level at which a thermal effect was seen
(unpublished results). The fluid filled bladder also acts as a
heat sink.
The bladder was filled to a volume of 0.3 ml with saline
and assumed to be a perfect sphere to calculate the treatment
time needed to give a light dose of 20-80 J cm-2. This does
not take account of internal reflectance within the bladder so
the true incident energy density may be greater than this. The
bladder was exposed through a lower abdominal incision and
during light exposure the adjacent bowel was shielded to
prevent PDT damage from forward scattering, as the rat
bladder is both thin enough to transmit a significant amount
of the light, and is also largely intraperitoneal. The power
output from the laser was monitored during each exposure
by an in-line power meter and adjusted if necessary, though
in general it remained stable. The output from the fibre was
also checked after each exposure and at intervals during the
higher energy treatments. Animals were sacrificed immedi-
ately following treatment and the bladder removed and pro-
cessed for fluorescence scanning as described above. The
effect of a cessation of vesical blood flow on the photo-
bleaching of sensitiser fluorescence was also studied in
animals killed (by intracardiac injection of barbiturates) just
before the start of light exposure.
Results
Intravenous administration
Fluorescence images are shown from representative sections
of normal rat bladder together with the corresponding H&E
stained slides. Control sections showed negligible auto-
fluorescence. At 1 h fluorescence was seen in all layers of the
bladder wall with fluorescence intensities in the well vas-
cularised layers of submucosa and serosa about twice that in
the muscle layers (Figure 2). Vascular endothelium fluoresced
brightly at this time. By 24 h after sensitisation a more
marked gradient of between 3.5 and 4 had developed between
the AlSPc fluorescence intensity in the superficial vs muscle
layers (Figure 3), and this differential was maintained at 72 h.
This gradient was due to more rapid elimination from the
muscle layers; fluorescence readings from muscle were
45 ± 5% at 24 h and 40 ± 5% at 72 h of their value at 1 h
compared with levels in the superficial layers of 70 ± 10%
and 62 ± 8% respectively.
Intravesical administration
We found the uptake of intravesical AlSPc mixture to be
patchy and unpredictable which mirrored the results in our
animal PDT studies (Pope & Bown, 1991). In some areas
high levels of fluorescence extending through the full thick-
ness of the bladder wall were seen adjacent to areas in which
there was no uptake (Figure 4). As the AlSPc mixture used
is relatively hydrophilic due to the predominance of the
trisulphonated fraction, we also investigated uptake of the
purified disulphonated derivative which is more lipid soluble
and may penetrate the bladder wall more effectively. This S2
fraction did appear to be taken up more evenly than the
mixture and did not penetrate the deeper layers (Figure 5).
However the distribution of the photosensitiser within the
bladder wall was still not as even as that seen after intra-
venous administration.
Figure 2 Fluorescence image I h after sensitisation with
0.5 mgkg-' AlSPc showing high fluorescence in the endothelium
of submicosal blood vessels. The upper colour bar scale indicates
fluorescence intensity. Final magnification x 120.MICROSCOPIC DETECTION OF PHTHALOCYANINE FLUORESCENCE 87
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Figure 3 a, 24 h after sensitisation with 5 mg kg-' AISPc. A
ratio of 3.5-4:1 in fluorescence intensity now exists between the
superficial layers (mucosa and lamina propria) and the deeper
(muscle) layers of the bladder wall. b, H&E stained section
corresponding to a. Final magnification x 450.
Figure 4 a, Intravesical administration of AISPc mixture
(100 gigml-', h), showing high though variable fluorescence
throughout the bladder wall. b, H&E stained section correspond-
ing to figure 4a. Final magnification x 60.
Figure 5 a, Intravesical administration of AlISPc S2
(100p~g ml', 1lh) showing more superficial uptake compared
with AlISPc mixture. b, H&E stained section corresponding to a.
Final magnification x 60.
Photobleaching studies
A high light fluence (80 J CM-2) in vivo resulted in almost
complete degradation of the sensitiser throughout the dose
range studied (0.5-5 mg kg-' AlISPc, 24 h prior to light
exposure), with only a thin rim of superficial fluorescence
remaining (Figure 6b). Smaller light doses caused a lesser
degree of photobleaching (Figure 6a) and a dose of 20 J CM-2
only reduced fluorescence in muscle by about 25% compared
with unexposed controls, though by proportionally less than
this in the superficial layers. This had the result of increasing
the ratio of the fluorescence intensities between mucosa/
lamina propria and muscle to about 5:1 after 20 J CM-2 and
greater than 10:1I after 8OJCM2 (compared with 3.5-4:1 in
unexposed controls). If the circulation was arrested immedi-
ately before irradiation then minimal photobleaching of the
fluorescence image occurred even using high light doses
(Figure 6c).
Discussion
In this work we present the quantitative imaging of
phthalocyanine fluorescence in the bladder using a highly
sensitive detection system. This is the first time that the
distribution of AlISPc fluorescence in the bladder has been
demonstrated in this way and to our knowledge the first
report of photobleaching of any photosensitiser in tissue
resolved at the microscopic level.
The porphyrins are the most commonly used photosen-
sitisers but in the case of HpD or DHE, which are complex
and poorly defined mixtures of products with varying
fluorescence properties, it is questionable whether the observed
fluorescence closely mirrors photoactivity (Moan & Sommer,
1981; Berns et at., 1984). The main aggregates formed with
phthalocyanines are dimers whose fluorescence appears to be
negligible and whose photoactivity is also very low compared
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Figure 6 Photobleaching effect of red light (675nm) in vivo on
bladder 24 h after sensitisation with 5 mgkg-' A1SPc (same as
Figure 3a). The sensitiser is progressively degraded with increas-
ing fluence (a - after 40 Jcm-2)and only a thin rim offluorescence
is seen in the mucosa after 80J cm-2(b). If the circulation is
arrested before irradiation little loss of fluorescence is seen (c -
80Jcm-2ex vivo).
to that of monomers (McCubbin, 1985; Spikes & Bommer, 1986). The interpretation of the correlation between
fluorescence and photoactivity has been examined previously forAlSPc (Barr etal.,1988; Berg etal., 1989), from which it
was concluded that fluorescence detection is selective in that
only the photoactive monomers are detected. Therefore these
fluorescence estimations reflect the concentration of photo- active sensitiser in tissue which is more relevant than the
total amount which will include inactive aggregates.
Timing oflight exposure
Tissue sensitiser concentration will depend on the time lapse before treatment as well as the administered dose. Again the
ideal is not known though most reported series have treated
at 48-72 h after sensitisation. Benson's group (1986) treated
at 3 h as in vivo fluorescence of bladder tumours under UV
light was greatest at this time. Not withstanding the
difficulties in relating HpD fluorescence to photoactivity, the
timing of light delivery should be when the most advan-
tageous ratio of concentration between tumour and normal
tissue occurs, which is not necessarily when the highest levels
are seen in tumour. Initially after injection there is also a
high level in normal tissue especially in well vascularised
areas such as the submucosa and serosa. It is only later that
the slower clearance of sensitiser from malignant tissue
results in a concentration difference. This ratio in rat colonic
tumours has been found in our laboratory to be greatest at
48 h, though only about 2:1 (Tralau et al., 1987), and it
would not be unreasonable to expect a similar situation in
bladder carcinoma. We have shown in this paper that the
ratio between normal mucosa and muscle remains fairly con-
stant, at between 3-4:1, though absolute values decline,
between 24 h and 72 h so it would therefore seem most
appropriate to treat bladder tumours around 48 h after sen-
sitisation. Later than this confers no advantage in the distri-
bution of photosensitiser in normal tissue and it is at 48 h
that the most advantageous ratio between tumour and nor-
mal tissue may be expected, though this should be clarified
when studies of AlSPc uptake in man are possible.
Photobleaching
During light exposure some photosensitiser molecules
become photodegraded and will neither produce singlet
oxygen nor fluoresce. This phenomenon was first described in
vitro by Moan (1986), and later in vivo by Mang et al.(1987)
who showed a loss of fluorescence and reduction in extract-
able porphyrin from a mouse ffammary tumour. A similar
response has been demonstrated in other tumour models. In
this work we have demonstrated photobleaching at the
microscopic level and shown that this process requires an
intact blood supply and has the effect ofreducing the amount
of photoactive sensitiser in the deeper muscle relative to the
superficial layers of the bladder wall. It may be possible to
use this phenomenon to increase the selectivity of clinical
PDT.
There are two conditions to be satisfied before a PDT
effect can occur. Firstly enough singlet oxygen must be pro-
duced to cause tissue necrosis. This requires a minimum
tissue concentration of photosensitiser as below this
threshold level it is destroyed by photobleaching before
sufficient singlet oxygen has been produced, whatever the
light dose. Secondly a given tissue effect depends on the
product of sensitiser concentration and light dose for which
there is reciprocity in the ranges most workers have studied
(Bown et al., 1986; Barr et al., 1987; Profio & Doiron, 1987).
If the sensitiser concentration is increased, the threshold light
dose is reduced and vice versa. This reciprocity is lost for low
concentrations of photosensitiser near the threshold level
(Potter et al., 1987) where photobleaching becomes more
important. The therapeutic ideal is to manipulate the
difference in concentration of photosensitiser between the
urothelium and underlying muscle to achieve photoactive
conditions in the former but sub-threshold concentrations in
the muscle. In this situation photobleaching of the sensitiser
in the muscle layers will spare it from unwanted damage
during light exposure though still produce tissue necrosis in
the mucosa. Additional selectivity in clinical practice may
result from the small differential in photosensitiser concentra-
tion to be expected between bladder tumour and adjacent
normal mucosa.
In conclusion this fluorescence technique defines and
quantifies photosensitiser distribution in tissue on the micro-
scopic level. We have studied AlSPc, but with appropriate
wavelength adjustment, it would be equally applicable to the
porphyrins. High magnifications may be used to localise
fluorescence to cellular structures as sensitivity is much
greater than with conventional fluorescence microscopy.
Unwanted photobleaching during acquisition of the image is
not a problem because of the low excitation powers used,
therefore rates ofphotobleaching of low sensitiser concentra-
tions caused by in vivo irradiation can be accurately assessed
(unpublished data). We found that a fluorescence intensity
gradient of 3-4:1 between superficial and deep layers of the
normal bladder wall was established from 24 h sensitisation
due to slower elimination from the superficial layers, and it is
suggested that the optimum time to treat bladder tumours is
around 48 h. If low photosensitiser doses, and necessarily
higher light doses, are employed then photobleaching may
further improve the selectivity of PDT damage between theMICROSCOPIC DETECTION OF PHTHALOCYANINE FLUORESCENCE 879
superficial and deep layers of the bladder wall. We have since
applied these parameters to an animal model of bladder
function, and produced a reliable necrosis of the bladder
mucosa without damaging the underlying musculature (Pope
& Bown, 1991). This has healed by the regeneration of
normal tissue without the permanent reduction in bladder
capacity or compliance which has been seen in some clinical
series subsequent to muscle layer fibrosis.
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